Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-23-004899

General Counsel/Secretary gave up 2,478 shares (to pay taxes)

  • General Counsel/Secretary acquired 6,076 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Samuel George A. III · General Counsel/Secretary

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-02-11 Exercise or conversion : show line 1 in the form +6,076 6,076 D
2023-02-11 Shares withheld for taxes : show line 2 in the form −2,478 $1.35 $3,345 3,598 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-02-11 Exercise or conversion : show line 3 in the form Restricted Stock Units −6,076 18,227 D
Loading xslF345X03/ownership.xml…